Latest News and Press Releases

Data Shows TAMP to be a Promising Approach for Local Delivery of Gemcitabine with Reduced Systemic Toxicity in Patients Diagnosed with Locally Advanced Pancreatic Cancer  Metabolic Imaging, Used to...

Strong Finish to FY25 with Q4 Ending Active Subscribers +20.1% YoY; Revenue up 20% YoY Highest Quarterly Revenue in Company History at $91.7M RTR Exits FY25 with Transformed Balance Sheet, Improved...

HOUSTON, April 14, 2026 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), a global leader in the chemical industry, has released its 2025 Sustainability Report, Vision to Value: Maintaining Our Focus....

Rivus Pharmaceuticals Announces First Patients Dosed in AMPLIFY Phase 2 Trial for HU6 in MASH

First-in-human clinical trial underway to evaluate safety, tolerability and pharmacodynamic activity of HB2198 in normal healthy volunteers.  A separate Phase 1 trial evaluating HB2198 in patients...

PRINCETON, N.J., April 14, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage,...

Cohealyx interim data show ~20-day reduction in time to graft vs benchmark, with strong investigator satisfaction and consistent performance across wounds.

There are 2 press releases, English and French, that need to be published on April 14, 2026 at 7:30 am.

LOUISVILLE, Ky., April 14, 2026 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech...

CALGARY, Alberta, April 14, 2026 (GLOBE NEWSWIRE) -- Canadians are open to embracing artificial intelligence (AI) in their homes, work, finances and even as a romantic partner, but many are taking...